Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine

In patients with human immunodeficiency virus (HIV) infection and advanced stage Hodgkin’s lymphoma (HL), treatment with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) and highly active antiretroviral therapy (ART) is feasible and effective, and the immunological response to ART has a